Search results

Highly specialised technology (HST) evaluations are recommendations on the use of new and existing highly specialised medicines and treatments within the NHS in England.

Ask an expert from NICE International, part of the UK's National Institute for Health and Care Excellence, to speak at a healthcare event in your country

The Innovative Licensing and Access Pathway (ILAP) is a unique initiative which works with medicine developers early on to help get new medicines to patients faster.

Home What NICE does Digital health...

Tools for building or evaluating a medtech evidence base with NICE

NICE fees for technology appraisals and highly specialised technologies

Managed access allows people to access promising new treatments that would otherwise not be recommended because it is too uncertain whether the treatment is cost-effective.

Learn from NICE International, part of the UK's National Institute for Health and Care Excellence, about how to improve your nation's health and wellbeing

We assess the value of digital health technologies that offer the greatest potential to improve health and wellbeing.

Access free webinars and paid-for masterclasses.

NICE's technology appraisal and highly specialised technologies guidance manual

Our experts can offer advice and support in contextualising our guidelines, or helping you adapt our content to your country or local context.

Check our list of appointed suppliers to find out which knowledge resources and services they can offer.

Home Implementing NICE guidance Cost saving, resource planning and audit {"@context":"http://schema.org","@type":"BreadcrumbList","itemListElemen

Smoking cessation positively impacts all 5 clinical areas identified by Core20PLUS5 adults.